RxDoctor Payments Data

Keliea Winstead, PA

Medical · Mc Kenzie, TNNPI 1003353699

Payments from drug & device makers

$441in general payments, 2019–2025

Across 22 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$173
  • Astellas Pharma US Inc$96
  • Otsuka America Pharmaceutical, Inc.$52
  • Lundbeck LLC$26
  • AstraZeneca$26
  • Pfizer$21
  • plus $47 from 4 others

What the payments were for

  • Food & beverage$38186%
  • Education$6014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$441 in reported general payments places this provider in the 45th percentile of 480 medical providers in Tennessee.

See all medical providers in Tennessee

Medicare billing

Part B allowed, 2024
$1,637
Medicare patients
25
Services billed
70

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide40$48,512
TrulicityDulaglutide28$28,262
OzempicSemaglutide30$27,826
RybelsusSemaglutide13$19,139
LinzessLinaclotide33$19,013
FarxigaDapagliflozin Propanediol20$18,262
RexultiBrexpiprazole11$17,287
JardianceEmpagliflozin13$11,654
EliquisApixaban13$11,102
XareltoRivaroxaban16$10,207
TrintellixVortioxetine Hydrobromide13$6,249
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,710
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen145$3,936
Albuterol Sulfate HfaAlbuterol Sulfate126$2,048
Humalog Kwikpen U-100Insulin Lispro12$1,766

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$14$46,96443 claims
AbbVieLinzess$173$19,01333 claims
AstraZenecaFarxiga$26$18,26220 claims
Otsuka America Pharmaceutical, Inc.Rexulti$52$17,28711 claims
PfizerEliquis$21$11,10213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 480 medical providers in Tennessee.

Other medical in Mc Kenzie

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →